Clinical trial
Community Intervention to Eliminate HCV Among People Who Use Drugs. Implementation Study in the Cities of Paris, Marseille, Lyon and Fort-de-France, France.
NCT05794646 is registered in ClinicalTrials.gov with ANRS, Emerging Infectious Diseases as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Community Intervention to Eliminate HCV Among People Who Use Drugs. Implementation Study in the Cities of Paris, Marseille, Lyon and Fort-de-France, France.
- Lead sponsor
- ANRS, Emerging Infectious Diseases
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- October 2, 2023
- Completion date
- September 30, 2025
- Enrollment
- 3,400 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
hcv, substance use disorders